Passage BIO (PASG) Asset Writedowns and Impairment (2023 - 2025)

Passage BIO's Asset Writedowns and Impairment history runs 3 years deep, the most recent figure standing at -$4000.0 for Q4 2025.

• In Q4 2025, Asset Writedowns and Impairment changed N/A year-over-year to -$4000.0; the TTM figure through Dec 2025 stood at $2.6 million (down 49.68% YoY), while the FY2025 annual figure was $2.6 million, down 49.68% from the prior year.
• Asset Writedowns and Impairment for Q4 2025 stood at -$4000.0, down from $37000.0 in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $5.4 million in Q3 2023, with the low at -$37000.0 in Q2 2025.
• The 3-year median for Asset Writedowns and Impairment is $438000.0 (2024), against an average of $1.9 million.
• The sharpest annual moves came in 2024 and 2025: Asset Writedowns and Impairment slipped 11.04% in 2024, then tumbled 108.45% in 2025.
• Passage BIO's Asset Writedowns and Impairment stood at $5.4 million in 2023, then fell by 11.04% to $4.8 million in 2024, then sank by 100.08% to -$4000.0 in 2025.
• Business Quant data shows PASG's Asset Writedowns and Impairment at -$4000.0 in Q4 2025, $37000.0 in Q3 2025, and -$37000.0 in Q2 2025.